10-27017749-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_014915.3(ANKRD26):​c.4259G>A​(p.Cys1420Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00229 in 1,613,164 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C1420F) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0017 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0024 ( 26 hom. )

Consequence

ANKRD26
NM_014915.3 missense

Scores

1
1
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.113

Publications

8 publications found
Variant links:
Genes affected
ANKRD26 (HGNC:29186): (ankyrin repeat domain containing 26) This gene encodes a protein containing N-terminal ankyrin repeats which function in protein-protein interactions. Mutations in this gene are associated with autosomal dominant thrombocytopenia-2. Pseudogenes of this gene are found on chromosome 7, 10, 13 and 16. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
ANKRD26 Gene-Disease associations (from GenCC):
  • thrombocytopenia 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • acute myeloid leukemia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • autosomal thrombocytopenia with normal platelets
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary thrombocytopenia and hematologic cancer predisposition syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01960659).
BP6
Variant 10-27017749-C-T is Benign according to our data. Variant chr10-27017749-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 210184.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00169 (258/152292) while in subpopulation SAS AF = 0.0102 (49/4824). AF 95% confidence interval is 0.00789. There are 0 homozygotes in GnomAd4. There are 134 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 258 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANKRD26NM_014915.3 linkc.4259G>A p.Cys1420Tyr missense_variant Exon 30 of 34 ENST00000376087.5 NP_055730.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANKRD26ENST00000376087.5 linkc.4259G>A p.Cys1420Tyr missense_variant Exon 30 of 34 5 NM_014915.3 ENSP00000365255.4

Frequencies

GnomAD3 genomes
AF:
0.00170
AC:
259
AN:
152174
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00340
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.0101
Gnomad FIN
AF:
0.000848
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.00157
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00333
AC:
826
AN:
248244
AF XY:
0.00383
show subpopulations
Gnomad AFR exome
AF:
0.000388
Gnomad AMR exome
AF:
0.00317
Gnomad ASJ exome
AF:
0.00219
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00192
Gnomad NFE exome
AF:
0.00239
Gnomad OTH exome
AF:
0.00614
GnomAD4 exome
AF:
0.00235
AC:
3438
AN:
1460872
Hom.:
26
Cov.:
31
AF XY:
0.00266
AC XY:
1930
AN XY:
726742
show subpopulations
African (AFR)
AF:
0.000748
AC:
25
AN:
33444
American (AMR)
AF:
0.00336
AC:
150
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.00237
AC:
62
AN:
26112
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39580
South Asian (SAS)
AF:
0.0104
AC:
898
AN:
86148
European-Finnish (FIN)
AF:
0.00145
AC:
77
AN:
53042
Middle Eastern (MID)
AF:
0.0193
AC:
111
AN:
5748
European-Non Finnish (NFE)
AF:
0.00174
AC:
1930
AN:
1111766
Other (OTH)
AF:
0.00305
AC:
184
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
166
331
497
662
828
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00169
AC:
258
AN:
152292
Hom.:
0
Cov.:
32
AF XY:
0.00180
AC XY:
134
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.000361
AC:
15
AN:
41564
American (AMR)
AF:
0.00340
AC:
52
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.0102
AC:
49
AN:
4824
European-Finnish (FIN)
AF:
0.000848
AC:
9
AN:
10610
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.00157
AC:
107
AN:
68018
Other (OTH)
AF:
0.00473
AC:
10
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
13
26
39
52
65
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00203
Hom.:
0
Bravo
AF:
0.00189
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00209
AC:
17
ExAC
AF:
0.00350
AC:
423
Asia WGS
AF:
0.00404
AC:
14
AN:
3476
EpiCase
AF:
0.00305
EpiControl
AF:
0.00356

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ANKRD26: BP4, BS1, BS2 -

Jan 26, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 01, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 29185836, 27931139, 28748566) -

Thrombocytopenia 2 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 15, 2016
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ANKRD26-related disorder Benign:1
Jun 05, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.12
CADD
Benign
17
DANN
Benign
0.68
Eigen
Benign
-0.71
Eigen_PC
Benign
-0.82
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.81
T;T
MetaRNN
Benign
0.020
T;T
MetaSVM
Benign
-0.41
T
PhyloP100
0.11
PrimateAI
Benign
0.43
T
PROVEAN
Pathogenic
-7.1
D;D
REVEL
Uncertain
0.45
Sift
Benign
0.095
T;T
Sift4G
Benign
0.24
T;T
Vest4
0.31
MVP
0.52
MPC
0.088
ClinPred
0.022
T
GERP RS
0.71
Varity_R
0.29
gMVP
0.044
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146159734; hg19: chr10-27306678; COSMIC: COSV105828142; API